BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02318368-completion@plaintrial.com
DTSTAMP:20261028T005107Z
DTSTART;VALUE=DATE:201701
SUMMARY:A Phase 2\, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus E
 rlotinib in Subjects With Previously Untreated Metastatic\, EGFR-mutated N
 SCLC and BDX004 Positive Label — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02318368
URL:https://plaintrial.com/trial/NCT02318368
END:VEVENT
END:VCALENDAR